Tuberculin skin test and/or interferon gamma release assay: is it still time to debate?

Not available.

[1]  M. Pai,et al.  Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Ferrara,et al.  Tuberculosis of the tongue in a patient with rheumatoid arthritis treated with methotrexate and adalimumab. , 2014, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[3]  A. Sanduzzi,et al.  Performance of the Tuberculin Skin Test and Interferon-γ Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches , 2014, The Journal of Rheumatology. Supplement.

[4]  E. Concia,et al.  [Diagnostic sensitivity of QuantiFERON-TB Gold In-Tube and tuberculin skin test in active tuberculosis: influence of immunocompromission and radiological extent of disease]. , 2012, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[5]  D. Galati,et al.  IFN-γ release assays in tuberculosis management in selected high-risk populations , 2009, Expert review of molecular diagnostics.

[6]  P. Kavsak,et al.  Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis. , 2007, Clinical biochemistry.